• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to letter to the editor: Letter by Chen et al. regarding article, "Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A population-based study".

作者信息

Garcia-Zamora Mar, García-Lluch Gemma, Moreno Lucrecia, Cháfer-Pericás Consuelo, Pardo Juan

机构信息

Research Group in Alzheimer Disease, Instituto de Investigación Sanitaria La Fe, Valencia, Spain; Cathedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, Valencia 46115, Spain.

Cathedra DeCo MICOF-CEU UCH, University Cardenal Herrera-CEU, Valencia 46115, Spain; Department of Pharmacy, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia 46115, Spain.

出版信息

Pharmacol Res. 2025 May;215:107701. doi: 10.1016/j.phrs.2025.107701. Epub 2025 Mar 19.

DOI:10.1016/j.phrs.2025.107701
PMID:40118353
Abstract
摘要

相似文献

1
Response to letter to the editor: Letter by Chen et al. regarding article, "Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A population-based study".对编辑来信的回复：陈等人就题为《评估钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）及其他抗糖尿病药物在阿尔茨海默病中的作用：一项基于人群的研究》的文章所写的信。
Pharmacol Res. 2025 May;215:107701. doi: 10.1016/j.phrs.2025.107701. Epub 2025 Mar 19.
2
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A population-based study.评估钠-葡萄糖共转运蛋白 2 抑制剂（SGLT2i）和其他抗糖尿病药物在阿尔茨海默病中的作用：一项基于人群的研究。
Pharmacol Res. 2024 Aug;206:107295. doi: 10.1016/j.phrs.2024.107295. Epub 2024 Jul 4.
3
Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂与老年2型糖尿病患者发生泌尿生殖系统感染的风险
Ther Adv Drug Saf. 2021 Mar 29;12:2042098621997703. doi: 10.1177/2042098621997703. eCollection 2021.
4
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂与二肽基肽酶-4（DPP4）抑制剂治疗新发痴呆症的比较：一项基于倾向评分匹配的人群研究及竞争风险分析
Front Cardiovasc Med. 2021 Oct 21;8:747620. doi: 10.3389/fcvm.2021.747620. eCollection 2021.
5
Commentary on "Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A population-based study".
Pharmacol Res. 2025 May;215:107702. doi: 10.1016/j.phrs.2025.107702. Epub 2025 Mar 19.
6
Impact of Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease.
Pharmacol Res. 2024 Nov;209:107473. doi: 10.1016/j.phrs.2024.107473. Epub 2024 Oct 18.
7
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting.比较真实世界环境中使用钠-葡萄糖共转运蛋白 2 抑制剂或胰高血糖素样肽-1 受体激动剂的 2 型糖尿病患者的药物维持率。
Diabetes Res Clin Pract. 2021 Oct;180:109035. doi: 10.1016/j.diabres.2021.109035. Epub 2021 Sep 4.
8
Sodium Glucose Cotransporter-2 Inhibitor Treatment and the Risk of Diabetic Ketoacidosis in Denmark: A Retrospective Cohort Study of Five Years of Use.钠-葡萄糖协同转运蛋白2抑制剂治疗与丹麦糖尿病酮症酸中毒风险：一项为期五年使用情况的回顾性队列研究
Curr Drug Saf. 2021;16(1):73-81. doi: 10.2174/1574886315666200819114629.
9
Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.钠-葡萄糖共转运蛋白 2 抑制剂和胰高血糖素样肽 1 受体激动剂治疗 2 型糖尿病的糖尿病视网膜病变和糖尿病黄斑水肿风险：来自全球联合数据库的真实世界数据研究。
Diabetologia. 2024 Jul;67(7):1271-1282. doi: 10.1007/s00125-024-06132-5. Epub 2024 Apr 8.
10
Comparing benefits from sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in randomized clinical trials: a network meta-analysis.随机临床试验中钠-葡萄糖协同转运蛋白2抑制剂与胰高血糖素样肽-1受体激动剂的获益比较：一项网状Meta分析
Minerva Cardiol Angiol. 2023 Apr;71(2):199-207. doi: 10.23736/S2724-5683.22.05900-2. Epub 2022 Feb 23.